Expert Pitch

Your teen may be secretly vaping; don’t ignore coronavirus signs

Cornell University
12-Mar-2020 12:25 PM EDT, by Cornell University

As COVID-19 continues to spread throughout communities around the world, public health messaging has suggested that teens may experience mild cases of the virus. However, teens who vape may show worsening symptoms, due to the unknown extent of lung injuries from electronic cigarette devices.

Sahara Byrne, professor of communications at Cornell University, studies when and why youth resist campaigns, interventions and policies designed to protect them from engaging in risky behaviors.

Byrne is part of a team of Cornell researchers who are studying the most effective health warnings to include in advertisements for electronic cigarettes and addressing a paradox presented by the required warnings: discouraging adolescents from developing nicotine addictions through e-cigarettes, but not scaring off adult smokers for whom e-cigarettes might represent a healthier alternative to combustible cigarettes.

Bio: https://communication.cals.cornell.edu/people/sahara-byrne/

Byrne says:

“I’m concerned about the teen population with coronavirus. The messaging is that it will be mild for them, but many adults in their lives do not know that they have been vaping. Around 30% of them have likely been vaping. Many keep it secret from their parents.

“It concerns me that parents may resist taking their teen to the hospital if symptoms worsen, under the belief that young people are not high risk. We don’t know what the extent of their lung injuries are, and we have no idea how this injury relates to coronavirus. It’s something to consider if you are a parent or in charge of a high population of teens and young adults.” 

For interviews contact:
Gillian Smith Office:
607-254-6235

Cell: 607-882-0327
Gillian.Smith@cornell.edu

Cornell University has dedicated television and audio studios available for media interviews supporting full HD, ISDN and web-based platforms.

- 30 -

 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
1.59728